Yiwen
Yiwen Chen, Hsin-Chu TW
| Patent application number | Description | Published |
|---|---|---|
| 20110058378 | Illumination Device with High Efficiency and Manufacture Method Thereof - An illumination device and a manufacture method thereof are provided. The illumination device includes a base, an illumination chip, and a sealant. The base has a surrounding side wall which encloses a containing space. The illumination chip is disposed within the containing space while the sealant fills the containing space and covers the illumination chip. The sealant has an outer surface which includes a center concave and a circular convex surrounding the center concave. The center concave is formed as a part of a spherical surface with no singular point. The connection between the center concave and the circular convex forms a circular ridge. | 03-10-2011 |
Yiwen Chen, Taipei TW
| Patent application number | Description | Published |
|---|---|---|
| 20120046123 | Golf Club - A golf club having a head is disclosed. The head comprises a base layer and a compounded transfer layer. The base layer has a coupling face. The compounded transfer layer is formed on the coupling face of the base layer. The compounded transfer layer has a dye layer and a protection layer. The dye layer is sandwiched between the base layer and the protection layer. | 02-23-2012 |
Yiwen Chu US
| Patent application number | Description | Published |
|---|---|---|
| 20150307753 | Conductive Resilient Hollow Microsphere, Adhesive Composition, and Adhesive Articles - A conductive resilient hollow microsphere comprises a conductive layer enclosing a resilient polymeric hollow microsphere. An adhesive composition includes an insulating adhesive component and a plurality of the conductive resilient hollow microspheres. Adhesive articles including the adhesive composition are also disclosed. Methods of making the same are also disclosed. | 10-29-2015 |
Yiwen Fang, Redondo Beach, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20160076046 | PROMOTER, PROMOTER CONTROL ELEMENTS, AND COMBINATIONS, AND USES THEREOF - The present invention provides DNA molecules that constitute fragments of the genome of a plant, and polypeptides encoded thereby. The DNA molecules are useful for specifying a gene product in cells, either as a promoter or as a protein coding sequence or as an UTR or as a 3′ termination sequence, and are also useful in controlling the behavior of a gene in the chromosome, in controlling the expression of a gene or as tools for genetic mapping, recognizing or isolating identical or related DNA fragments, or identification of a particular individual organism, or for clustering of a group of organisms with a common trait. One of ordinary skill in the art, having this data, can obtain cloned DNA fragments, synthetic DNA fragments or polypeptides constituting desired sequences by recombinant methodology known in the art or described herein. | 03-17-2016 |
Yiwen Huang, Hsinchu City TW
| Patent application number | Description | Published |
|---|---|---|
| 20140124798 | LIGHT-EMITTING ELEMENT AND THE LIGHT-EMITTING ARRAY HAVING THE SAME - A light-emitting element includes: a light-emitting structure; a plurality of first contact portions separately on the light-emitting structure; and a plurality of reflective portions disposed separately among the plurality of first contact portions. | 05-08-2014 |
| 20150311416 | LIGHT-EMITTING ELEMENT AND THE LIGHT-EMITTING ARRAY HAVING THE SAME - A light-emitting element includes a light-emitting structure, a plurality of first contact portions disposed separately on the light-emitting structure, and a plurality of reflective portions disposed separately among the first contact portions. | 10-29-2015 |
Yiwen Li, Jersey City, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090297529 | ANTI-FLT3 ANTIBODIES - The present invention provides fully human antibodies that specifically bind to human FLT3 within extracellular domains 4 or 5 with high affinity. The invention further provides methods of treating leukemia by administering an effective amount of an antibody either alone or in combination with an anti-cancer agent or treatment including methotrexate. | 12-03-2009 |
| 20110008355 | ANTI-FLT3 ANTIBODIES - The present invention provides fully human antibodies that specifically bind to human FLT3 within extracellular domains 4 or 5 with high affinity. The invention further provides methods of treating leukemia by administering an effective amount of an antibody either alone or in combination with an anti-cancer agent or treatment including methotrexate. | 01-13-2011 |
| 20110091470 | ANTI-FLT3 ANTIBODIES - The present invention provides fully human antibodies that specifically bind to human FLT3 within extracellular domains 4 or 5 with high affinity. The invention further provides methods of treating leukemia by administering an effective amount of an antibody either alone or in combination with an anti-cancer agent or treatment including methotrexate. | 04-21-2011 |
Yiwen Li, Arcadia, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20120186997 | LAYERED ENZYME COMPOSITIONS FOR USE WITH ANALYTE SENSORS - Embodiments of the invention provide amperometric analyte sensors having optimized elements such as electrodes formed from sputtered platinum compositions as well as layers of material selected to optimize the characteristics of a wide variety of sensor elements and sensors. While embodiments of the innovation can be used in a variety of contexts, typical embodiments of the invention include glucose sensors used in the management of diabetes. | 07-26-2012 |
| 20120190950 | ELECTRODE COMPOSITIONS FOR USE WITH ANALYTE SENSORS - Embodiments of the invention provide amperometric analyte sensors having optimized elements such as electrodes formed from sputtered platinum compositions as well as layers of material selected to optimize the characteristics of a wide variety of sensor elements and sensors. While embodiments of the innovation can be used in a variety of contexts, typical embodiments of the invention include glucose sensors used in the management of diabetes. | 07-26-2012 |
| 20130328572 | APPLICATION OF ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY IN SENSOR SYSTEMS, DEVICES, AND RELATED METHODS - A diagnostic Electrochemical Impedance Spectroscopy (EIS) procedure is applied to measure values of impedance-related parameters for one or more sensing electrodes. The parameters may include real impedance, imaginary impedance, impedance magnitude, and/or phase angle. The measured values of the impedance-related parameters are then used in performing sensor diagnostics, calculating a highly-reliable fused sensor glucose value based on signals from a plurality of redundant sensing electrodes, calibrating sensors, detecting interferents within close proximity of one or more sensing electrodes, and testing surface area characteristics of electroplated electrodes. Advantageously, impedance-related parameters can be defined that are substantially glucose-independent over specific ranges of frequencies. An Application Specific Integrated Circuit (ASIC) enables implementation of the EIS-based diagnostics, fusion algorithms, and other processes based on measurement of EIS-based parameters. | 12-12-2013 |
| 20130331674 | APPLICATION OF ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY IN SENSOR SYSTEMS, DEVICES, AND RELATED METHODS - A diagnostic Electrochemical Impedance Spectroscopy (EIS) procedure is applied to measure values of impedance-related parameters for one or more sensing electrodes. The parameters may include real impedance, imaginary impedance, impedance magnitude, and/or phase angle. The measured values of the impedance-related parameters are then used in performing sensor diagnostics, calculating a highly-reliable fused sensor glucose value based on signals from a plurality of redundant sensing electrodes, calibrating sensors, detecting interferents within close proximity of one or more sensing electrodes, and testing surface area characteristics of electroplated electrodes. Advantageously, impedance-related parameters can be defined that are substantially glucose-independent over specific ranges of frequencies. An Application Specific Integrated Circuit (ASIC) enables implementation of the EIS-based diagnostics, fusion algorithms, and other processes based on measurement of EIS-based parameters. | 12-12-2013 |
| 20140012115 | PLASMA DEPOSITED ADHESION PROMOTER LAYERS FOR USE WITH ANALYTE SENSORS - Embodiments of the invention provide methods and materials for making analyte sensors having a plurality of layered elements such as amperometric glucose sensors that are used by diabetic individuals to monitor blood sugar concentrations. Embodiments of the invention utilize plasma deposition technologies to form thin films of adhesion promoting compositions useful in such sensors. Sensors that incorporate the thin film compositions formed by these processes exhibit a number of desirable characteristics. | 01-09-2014 |
Yiwen Liu, Shenzhen City CN
| Patent application number | Description | Published |
|---|---|---|
| 20100128718 | Supporting Method for REFER Message Expansion Parameter - The present invention discloses a method for supporting extended parameter(s) in a REFER message, applied in a system comprising a parameter proxy server that can receive and forward the REFER message; upon receiving the REFER message including the extended parameter(s), the parameter proxy server performing the following processing: storing said extended parameter(s); sending the REFER message to the indicated party of the message; upon receiving a third party message sent by said indicated party and indicated by the method parameter in the REFER message, adding the extended parameter(s) stored into the third party message; sending the third party message to said third party. With the present invention, those IMS intelligent terminals that do not support the extended parameter(s) in the REFER message can more fully utilize the REFER message to use the abundant services provided by NGN. | 05-27-2010 |
Yiwen Liu, Dalian CN
| Patent application number | Description | Published |
|---|---|---|
| 20130313172 | ZERO-VALENT IRON TWO-PHASE ANAEROBIC REACTOR - The invention, belongs to the field of wastewater treatment technology, is a two-phase anaerobic reactor enhanced by addition of zero valent iron (ZVI). In the reactor, 2˜4 ZVI-filling layers are settled in the middle of the anaerobic hydrolysis-acidification tank, the effluent of which is fed into the rear anaerobic methanogenic tank. The degradation of organics is effectively enhanced in the anaerobic hydrolysis-acidification tank with dosing of ZVI, which may produce more acetic acid that is a desired substrate for the subsequent methanogenesis. Meanwhile, the acidic environment of the hydrolysis-acidification tank is helpful for the dissolution of ZVI to maintain its activity. The reactor is reasonably designed with high performance and strong shock resistance in anaerobic treatment of various wastewaters. Tests in lab-scale showed that hydrolysis-acidification and methanogenesis in this combined system were significantly improved compared with a reference reactor without addition of ZVI. | 11-28-2013 |
| 20140061125 | WASTEWATER PROCESSING METHOD OF HYDROLYSIS-ACIDIFICATION ENHANCED BY ADDITION OF ZERO-VALENT IRON (ZVI) - The invention discloses a wastewater processing method of hydrolysis-acidification enhanced by addition of zero-valent iron (ZVI), including the following steps: 3˜6 ZVI-filling layers are settled in the middle of an anaerobic hydrolysis-acidification reactor. Excess sludge taken from sewage treatment plant using as seed sludge is added into this anaerobic hydrolysis-acidification reactor for startup and domestication. In the present invention, ZVI are added into this anaerobic hydrolysis-acidification reactor to accelerate organic matters degradation and produce more acetic acids, accompanied with higher COD removal obtained. ZVI can be protected from rust in this anaerobic biological environment due to the air isolation. Also, ZVI can enhance anaerobic hydrolysis of wastewater through reducing refractory pollutants involved in wastewaters. This novel method made the effluent from the hydrolysis-acidification reactor present less COD concentration and simpler substrate form, benefiting for the following anaerobic methanogenesis or aerobic treatment. | 03-06-2014 |
Yiwen Sun, Pudong CN
| Patent application number | Description | Published |
|---|---|---|
| 20150259232 | TREATMENT OF PRODUCED WATER CONCENTRATE - Water, for example produced water from a steam assisted gravity drainage (SAGD) or cyclic steam stimulation (CSS) heavy oil recovery operation, is treated, for example to recover water re-use in creating steam. The produced water is concentrated, for example in one or more thermal treatment devices such as an evaporator and a crystallizer. A solvent and a compound or solution comprising multivalent cations is added to the concentrate. Solids precipitate and are separated from the concentrate. The solvent may be recovered for re-use in treating more concentrate. | 09-17-2015 |
Yiwen Tang, Sunnyvale, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20140335143 | Polymer Blends For Drug Delivery Stent Matrix With Improved Thermal Stability - Various embodiments of the present invention generally relate to a polymer blend composition used for coating a medical device that exhibits improved thermal stability. The invention also encompasses implantable medical devices coated the aforementioned coating. | 11-13-2014 |
| 20140356519 | ELASTIN-BASED COPOLYMERS AND METHOD OF USING - A copolymer comprising a block of an elastin pentapeptide and method of making and using the copolymer are provided. | 12-04-2014 |
| 20140363563 | ELASTIN-BASED COPOLYMERS - A copolymer comprising a block of an elastin pentapeptide and method of making and using the copolymer are provided. | 12-11-2014 |
| 20140370073 | BIOLOGICALLY DEGRADABLE COMPOSITIONS FOR MEDICAL APPLICATIONS - A medical article is disclosed, comprising a biologically degradable AB block copolymer and a biologically degradable polymer that is capable, at equilibrium and at room temperature, of absorbing less than about 5 mass % water. | 12-18-2014 |
| 20140377325 | COATINGS FOR IMPLANTABLE DEVICES COMPRISING POLYMERS OF LACTIC ACID AND METHODS FOR FABRICATING THE SAME - Coatings for an implantable medical device and a method of fabricating thereof are disclosed, the coatings comprising polymers of lactic acid. | 12-25-2014 |
| 20150150989 | Plasticizers For Coating Compositions - A biocompatible plasticizer useful for forming a coating composition with a biocompatible polymer is provided. The coating composition may also include a biobeneficial polymer and/or a bioactive agent. The coating composition can form a coating on an implantable device. The implantable device can be used to treat or prevent a disorder such as atherosclerosis, thrombosis, restenosis, hemorrhage, vascular dissection or perforation, vascular aneurysm, vulnerable plaque, chronic total occlusion, claudication, anastomotic proliferation for vein and artificial grafts, bile duct obstruction, ureter obstruction, tumor obstruction, or combinations thereof | 06-04-2015 |
| 20150151030 | BIOABSORBABLE COATING WITH TUNABLE HYDROPHOBICITY - The present invention relates to implantable medical devices coated with polymer having tunable hydrophobicity and their use in the treatment of vascular diseases. | 06-04-2015 |
Yiwen Tao, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20140363845 | CHOLESTEROL-BASED MEDIA SUPPLEMENTS FOR CELL CULTURE - The disclosure provides compositions and methods for high density cell culture and banking of cholesterol auxotrophic cells. | 12-11-2014 |
| 20150037841 | Use of Molecular Chaperones for the Enhanced Production of Secreted, Recombinant Proteins in Mammalian Cells - The present invention relates to a method for increased production of a secreted, recombinant protein product through the introduction of molecular chaperones in a mammalian host cell. The present invention also relates to a mammalian host cell with enhanced expression of a secreted recombinant protein product by coexpressing at least one chaperone protein. | 02-05-2015 |
Yiwen Yan, Guangzhou CN
| Patent application number | Description | Published |
|---|---|---|
| 20140322347 | ORAL LIQUID FOR TREATING ALLERGIC COUGH - A medicine for treating allergic cough comprises 5 to 25 parts by weight of | 10-30-2014 |
Yiwen Zhang, Tianjin CN
| Patent application number | Description | Published |
|---|---|---|
| 20150079418 | Thread Rolling Fixed Length Spiral Rib Steel Wire - The present invention discloses a thread rolling fixed length, spiral rib steel wire used in prestressed concrete sleepers and track plates, including a 2.5 m long spiral rib prestressed steel wire, where both ends of said steel wire have continuous external thread section whose length is 30±2 mm, wherein, the surface of said steel wire has four parallel winding spiral ribs whose cross section is trapezoidal and lead is 41˜55 mm, the nominal diameter of said steel wire is 9.5 mm, 10.0 mm, or 10.5 mm, and the elastic-limit of said steel wire is larger than 1200N/mm | 03-19-2015 |
Yiwen Zhang, Bedford, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20130154124 | METHOD FOR PACKAGING SEMICONDUCTORS AT A WAFER LEVEL - A package and method for packaging a semiconductor device formed in a surface portion of a semiconductor wafer. The package includes: a dielectric layer disposed on the surface portion of the semiconductor wafer having a device exposing opening to expose one of the devices and an electrical contacts pad opening to expose an electrical contact pad; and a porous material in the device exposing opening over said one of the devices. | 06-20-2013 |
Yiwen Zhang, Beijing CN
| Patent application number | Description | Published |
|---|---|---|
| 20130179879 | AUTO-DISCOVERY SERVICE AND METHOD OF DISCOVERING APPLICATIONS WITHIN A VIRTUAL NETWORK - Embodiments provide a system including a first host computing device that includes a first virtual machine (VM) and a first application. The system also includes a second host computing device including a virtualization software layer, a second VM, and an auto-discovery service at least partially instantiated within the virtualization software layer. The auto-discovery service is configured to receive a message and an auto-discovery packet from a second application executing on the second VM. The auto-discovery service inserts an option into the auto-discovery packet, and transmits the auto-discovery packet to the first application. The option in the auto-discovery packet includes the message received from the second application. | 07-11-2013 |